RETA
Envestnet Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,176
| Closed | -$732K | – | 4194 |
|
|
2023
Q2 | $732K | Buy |
7,176
+2,993
| +72% | +$305K | ﹤0.01% | 2981 |
|
|
2023
Q1 | $380K | Sell |
4,183
-4,860
| -54% | -$442K | ﹤0.01% | 3324 |
|
|
2022
Q4 | $344K | Buy |
+9,043
| New | +$344K | ﹤0.01% | 3338 |
|
|
2021
Q4 | – | Sell |
-2,626
| Closed | -$264K | – | 3968 |
|
|
2021
Q3 | $264K | Sell |
2,626
-7
| -0.3% | -$704 | ﹤0.01% | 3360 |
|
|
2021
Q2 | $373K | Sell |
2,633
-98
| -4% | -$13.9K | ﹤0.01% | 3151 |
|
|
2021
Q1 | $272K | Buy |
2,731
+384
| +16% | +$38.2K | ﹤0.01% | 3194 |
|
|
2020
Q4 | $290K | Buy |
+2,347
| New | +$290K | ﹤0.01% | 2941 |
|
|
2020
Q3 | – | Sell |
-1,732
| Closed | -$270K | – | 3217 |
|
|
2020
Q2 | $270K | Buy |
+1,732
| New | +$270K | ﹤0.01% | 2733 |
|
|
2020
Q1 | – | Sell |
-1,690
| Closed | -$345K | – | 3179 |
|
|
2019
Q4 | $345K | Buy |
+1,690
| New | +$345K | ﹤0.01% | 2673 |
|